Midazolam suppresses glioma progression by attenuating neuronal activity and downregulating IGF1 signaling.
- DOI
- 10.3724/abbs.2026109
- Published
- 2026 Sep 22
- Container
- Acta biochimica et biophysica Sinica
- Publisher
- Not recorded
- Open access
- unknown
Credibility signals
limited evidence Score 43/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.
Show all credibility signals
- cautionDOI registered: No matching Crossref record was present in this response.
- cautionDOI resolves: No matching Crossref record was present in this response.
- not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility.
- not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made.
- not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made.
- not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made.
- not scoredROR affiliation: Not checked or no result supplied; no credibility inference made.
- not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete.
- not scoredOpen access status: Not checked or no result supplied; no credibility inference made.
- not scoredPublication license: Not checked or no result supplied; no credibility inference made.
- not scoredPublication version: A publication version was supplied but is not scored.
- cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty.
Cite this work
BibTeX
@article{allodium:10.3724/abbs.2026109,
title = {Midazolam suppresses glioma progression by attenuating neuronal activity and downregulating IGF1 signaling.},
author = {Qi Z and Ye Z and Chan K and Wu Y and Yu Y and Hu Y and Lu Y and Ren J and Yao M and Wang Z},
year = {2026},
journal = {Acta biochimica et biophysica Sinica},
doi = {10.3724/abbs.2026109},
url = {https://doi.org/10.3724/abbs.2026109}
}RIS
TY - JOUR TI - Midazolam suppresses glioma progression by attenuating neuronal activity and downregulating IGF1 signaling. AU - Qi Z AU - Ye Z AU - Chan K AU - Wu Y AU - Yu Y AU - Hu Y AU - Lu Y AU - Ren J AU - Yao M AU - Wang Z PY - 2026 JO - Acta biochimica et biophysica Sinica DO - 10.3724/abbs.2026109 UR - https://doi.org/10.3724/abbs.2026109 ER -
APA
Z, Q., Z, Y., K, C., Y, W., Y, Y., Y, H., Y, L., J, R., M, Y., & Z, W. (2026). Midazolam suppresses glioma progression by attenuating neuronal activity and downregulating IGF1 signaling.. Acta biochimica et biophysica Sinica. https://doi.org/10.3724/abbs.2026109
Source records
- pubmed · retrieved 2026-09-25T01:52:41.779Z